Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Remix Therapeutics
Biotech
Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders
Ex-Eisai leader Cheung tapped as new NextPoint chief. Gregory to lead Regeneron's new cell therapy unit following 2seventy moves. Sanofi swaps CFOs.
Max Bayer
,
Gabrielle Masson
Feb 2, 2024 9:30am
Get ready for the Roche (Remix), a $30M small molecule deal
Jan 3, 2024 7:00am
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am
Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders
May 27, 2022 9:30am
Remix closes $70 million series B but what's in the pipeline?
May 17, 2022 6:45am
Remix debuts with $81M to 'reprogram' disease-causing RNA
Dec 8, 2020 7:15am
